As our Kaplan-Meier curves measured incidence for the first 36-months following the initial appointment, this discrepancy may also suggest that the likelihood of adenoma development for MSH2 and EPCAM may be attenuated following consistent surveillance. This evidence concerns the gene EPCAM and adenoma.